2024, Biogen anticipates a return to earnings growth

Biogen anticipates a return to earnings growth | Image Credit: statnews.com
Biogen anticipates a return to earnings growth | Image Credit: statnews.com

Biogen’s (BIIB.O) shares dropped 5% in premarket trade on Tuesday after the firm’s fourth-quarter earnings missed Wall Street predictions. The business opens new tab and forecasts a return to yearly profit growth following cost reduction and a bump up in sales of its newer products.

Biogen has trimmed staff, started reviewing its biosimilars division, and closed a $6.5 billion agreement to acquire Reata, a developer of medications for rare diseases, in an effort to get back on track since CEO Christopher Viehbacher took over the company in late 2022.

Also Read: Nvidia Stock Prediction: Following a record-breaking day, NVDA reaches new all-time highs following hours

Additionally, it is depending on more recent medications to fuel growth over the next years, such the Alzheimer’s treatment Leqembi, which was created in collaboration with Eisai (4523.T), opens new tab.

Compared to LSEG forecasts of $15.65 per share, Biogen projected an adjusted profit per share for 2024 of between $15 and $16. A five percent rise is represented by the anticipated range’s midpoint.

But in 2024, product sales are predicted to remain unchanged. The business anticipates a modest increase in Leqembi sales following its complete clearance last year.

“Declining sales and profit over the past few years is not unexpected when dealing with patent expirations. How to resume growth is the question, according to CEO Viehbacher.

Following its decision last month to return the rights for the Alzheimer’s disease therapy Aduhelm and on sluggish demand for the multiple sclerosis drug Tecfidera and the spinal muscular atrophy treatment Spinraza, Biogen missed Wall Street projections for fourth-quarter earnings.

The company’s earnings for the fourth quarter was negatively impacted by Aduhelm departure costs by 35 cents.

Sales of Biogen’s once-blockbuster medication Tecfidera, which is up against competition from a less expensive generic alternative, dropped 17.8% to $244.3 million in the fourth quarter, falling short of LSEG projections of $252.3 million.

Analysts had predicted that the business would make $3.18 per share, but instead it announced an adjusted profit of $2.95 per share.

Revenue missed projections of $2.47 billion, falling 6.2% to $2.39 billion.

Source:
https://www.reuters.com/business/healthcare-pharmaceuticals/biogen-fourth-quarter-profit-misses-aduhelm-exit-costs-2024-02-13/


  • Krispy Kreme’s Ghostbusters Doughnut Collection – A Spooky Collaboration for 2024

    Krispy Kreme’s Ghostbusters Doughnut Collection – A Spooky Collaboration for 2024

    Krispy Kreme has always been known for its creative and exciting limited-edition doughnuts, and this October, the company has outdone itself once again. In celebration of the 40th anniversary of the cult-classic movie Ghostbusters, Krispy Kreme has launched a new collection of doughnuts inspired by the beloved film, offering fans a deliciously spooky treat that…

  • Ticketmaster to Pioneer New Apple Wallet Ticketing Feature on iOS 18

    Ticketmaster to Pioneer New Apple Wallet Ticketing Feature on iOS 18

    As the world anticipates the release of iOS 18, Apple has unveiled a revolutionary enhancement to its Apple Wallet—a feature that promises to transform the ticketing industry. Leading the charge is Ticketmaster, which is set to be the first major ticketing platform to implement this new feature. This collaboration between Apple and Ticketmaster will offer…

  • Breaking News – Addison’s Disease Rare Condition Affecting the Adrenal Glands

    Breaking News – Addison’s Disease Rare Condition Affecting the Adrenal Glands

    October 2024 – Addison’s disease, also known as primary adrenal insufficiency, is a rare yet serious condition that occurs when the adrenal glands fail to produce sufficient levels of cortisol and aldosterone. This hormonal imbalance can have a profound effect on various bodily functions, and without timely diagnosis and treatment, the disease can become life-threatening.…

  • Addison’s Disease – Rare Endocrine Disorder and Recent Advances in Treatment

    Addison’s Disease – Rare Endocrine Disorder and Recent Advances in Treatment

    Addison’s disease, also known as primary adrenal insufficiency, is a rare but potentially life-threatening condition caused by damage to the adrenal glands, which results in insufficient production of essential hormones such as cortisol and aldosterone. First identified by British physician Thomas Addison in 1855, this disorder can affect people of all ages, though it remains…

  • Northern Lights Forecast: Spectacular Aurora Expected Tonight

    Northern Lights Forecast: Spectacular Aurora Expected Tonight

    Tonight could offer a rare and stunning display of the Northern Lights, or Aurora Borealis, visible across several parts of the U.S. due to a severe geomagnetic storm forecasted by the National Oceanic and Atmospheric Administration (NOAA). This storm, rated G4 on a scale from G1 (minor) to G5 (extreme), is the result of a…

  • WWE Bad Blood 2024: Everything You Need to Know – Date, India Timings, Full Match Card, and How to Watch

    WWE Bad Blood 2024: Everything You Need to Know – Date, India Timings, Full Match Card, and How to Watch

    WWE fans across the globe are eagerly awaiting the return of one of the most iconic pay-per-view events, WWE Bad Blood, which makes its triumphant comeback after two decades. Here’s everything you need to know about WWE Bad Blood 2024, including the match card, viewing options, and key event details. Event Overview Date: WWE Bad…

  • UNLV vs Syracuse Football Thriller – October 4, 2024

    UNLV vs Syracuse Football Thriller – October 4, 2024

    In a dramatic showdown on October 4, 2024, the Syracuse Orange narrowly defeated the UNLV Rebels 44-41 in overtime at Allegiant Stadium, Las Vegas. Both teams entered the game with matching 4-1 records, and the contest lived up to the hype with high-paced scoring and critical plays. First Quarter: Syracuse Takes Early Lead Syracuse took…

  • Joker 2’s Rotten Tomatoes Score: A Disappointing Turn for the Sequel?

    Joker 2’s Rotten Tomatoes Score: A Disappointing Turn for the Sequel?

    Joker: Folie à Deux, the highly anticipated sequel to 2019’s Joker, has landed with less than stellar reviews, leaving fans and critics divided. Despite initial excitement, the Rotten Tomatoes score for the movie has raised concerns about its overall impact and reception. As of early October 2024, Joker 2 holds a disappointing Rotten Tomatoes score…

  • Student Loan Forgiveness Program from Biden Clarifies Legal Hurdles – Who Stands to Benefit?

    Student Loan Forgiveness Program from Biden Clarifies Legal Hurdles – Who Stands to Benefit?

    In a significant legal victory for President Joe Biden’s administration, a federal judge recently lifted a block on Biden’s student loan forgiveness plan, clearing the way for millions of borrowers to receive relief. The latest iteration of this program, developed after the Supreme Court struck down an earlier attempt, aims to wipe out some or…

  • Europa League Showdown: How to Livestream Porto vs. Manchester United from Anywhere (2024)

    Europa League Showdown: How to Livestream Porto vs. Manchester United from Anywhere (2024)

    The UEFA Europa League 2024 is heating up, and one of the marquee matchups sees FC Porto take on Manchester United at the iconic Estádio do Dragão. With both clubs eager to make their mark in the tournament, fans worldwide are eager to follow the action. Here’s a guide on how to stream this highly…